isopropyl myristate + liquid paraffin: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
isopropyl myristate + liquid paraffin: clinical details
Prescribing considerations
- Confirm that a wash-off soap substitute, rather than a leave-on emollient, meets the intended treatment role.
- Assess smoking, open-flame, cooking, oxygen-use and mobility risks, particularly where residue may accumulate on fabrics.
- Explain slip prevention and cleaning of baths, showers and floors.
- Consider another formulation if local irritation occurs or acceptability limits use.
Contraindications and cautions
- Known hypersensitivity to either active ingredient or any excipient.
Monitoring
- Skin tolerance and whether dryness, itching or inflammation is improving.
- Signs of local irritation, allergic reaction or secondary skin infection.
- Understanding of fire and slip precautions where ongoing use is expected.
Clinical pharmacology
Isopropyl myristate and liquid paraffin act as occlusive emollients in the stratum corneum, reducing transepidermal water loss and softening dry skin. Cetomacrogol provides non-ionic cleansing action suitable for use as a soap substitute.
Formulation and product differences
- The selected product is a white, opaque wash-off gel rather than a leave-on moisturiser.
- It cleanses gently without foaming and is rinsed from the skin.
- The formulation contains phenoxyethanol and cetomacrogol among its excipients.
isopropyl myristate + liquid paraffin interactions
No medicine interactions are known for the selected product. Apply other topical treatments separately to avoid diluting or spreading them unintentionally.
Topical corticosteroids and other medicated skin treatments
Apply separately and ask the prescriber which product should be used first.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.